Former president of Mexico, Vicente Fox, has turn into a director at Helix TCS (OTCQB: HLIX) as it bids to increase its international footprint.
Fox was Mexico’s 55th president and he held workplace from 2000 to 2006 following serving as governor of Guanajuato. He brings considerable political clout to Helix, while it is worth noting that he is embroiled in a lengthy-operating feud with existing president Andres Manuel Lopez Obrador.
Fox regularly clashed with Obrador, who was then mayor of Mexico City, through the second half of his presidency. They sit at opposite ends of the political spectrum and Fox attempted unsuccessfully to have him removed from workplace.
There is nevertheless lots of animosity involving them and final week Fox mentioned the new president “should be sent to jail”. He could not get on with the president, but Fox is positive to have political connections that can assistance Helix thrive in Mexico and the wider Latin American marketplace.
He is currently established in the cannabis business as he also sits on the board of Khiron Life Sciences, which continues to expand across South America. His new function at Helix is developed to assistance the firm increase sales in key export hubs exactly where cannabis producers can advantage from the solutions it presents.
Helix is not a rival to Khiron, as it delivers ancillary solutions for the cannabis business. It delivers provide chain management, operating with two,000 buyers in 33 U.S. states and 5 other nations, and it claims to have processed a lot more than $18 billion in marijuana sales.
“A new business is getting born, with higher ethical requirements, attracting huge investment in healthcare and overall health goods, bringing financial development and jobs to communities and nations, and I am proud to be component of it,” mentioned Fox.
He is following in the footsteps of former Israeli prime minister Ehud Barak, who is the higher-profile chairman of cannabis producer InterCure (TLV: INCR).
Israel is a pioneer in the medicinal marijuana business and it has just began exporting following a transform in legislation. Australian cannabis producer AusCann (ASX: AC8) has just hired Ido Kanyon, a senior executive at major Israeli producer Teva Pharmaceutical Industries, to turn into its new chief executive. It coincides with AusCann’s move from pure cultivator to pharmaceutical manufacturer.